Humana
- Market cap
- 47.61B
- P/E (TTM)i
- 37.48
- P/Bi
- 2.48
- EPSi
- 9.84
- Div yieldi
- 0.89%
- 52W posi
- 88%
Anonymous reader poll. Unscientific, not investment advice.
Humana shares were changing hands at 396.51, down 1.92% on the day. The company carries a market value of roughly 47.61B, the #477 most valuable US-listed company we track. Valuation-wise, the P/E sits at 36.07, 62% above the five-year average of 22.22. The stock also carries a trailing dividend yield of 0.89%. Wall Street's 22-analyst consensus lands on Buy, with a price target averaging 428.05 (+8% from here). Against a 52-week band of 161.90-428.88, the shares are currently 88% of the way up.
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 25% of the universe, above its 200-day average.
- Signal has read BUY for 4 weeks.
- Its last 8 Buy calls have actually lost 5% on average three months out - the strategy's edge here has come from the basket, not from this ticker.
- Recent price momentum is +18.1% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 2.4% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 977 U.S. stocks StockVane covers.
Valuation C
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 38.2x | Better than 18% |
| Forward P/E | 31.0x | Better than 20% |
| Price / Sales | 0.3x | Better than 97% |
| P/E vs own 5-yr range | 95th pctl | Better than 6% |
Growth C-
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 11.8% | Better than 71% |
| Net income CAGR (3Y) | -24.9% | Better than 12% |
| Free cash flow CAGR (3Y) | -52.3% | Better than 2% |
Profitability D+
How much profit the business keeps from each dollar of sales and capital.
| Net margin | 0.9% | Better than 16% |
| Return on equity | 7.0% | Better than 26% |
Momentum A
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 2.4% | Better than 61% |
| 6-month return | 105.4% | Better than 96% |
| 12-month return (ex latest month) | 37.5% | Better than 72% |
| Distance below 52-week high | 5.8% | Better than 89% |
Financial Health D+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Debt to assets | 25.3% | Better than 58% |
| Interest coverage | 3.5x | Better than 32% |
| Free cash flow / net income | 31.6% | Better than 8% |
Analyst View D+
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 54.5% | Better than 30% |
| Upside to average target | 5.9% | Better than 11% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector, so capital-light software tends to grade lower there than utilities. Recomputed every 6 hours from our market data. Not investment advice, and not tailored to your financial situation, goals, or risk tolerance.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 404.27
- Open
- 410.00
- Day range
- 394.81 - 410.01
- Avg price
- 402.21
- Volume
- 1.83M
- Turnover
- 735.22M
- Turnover ratei
- 1.53%
- Volume ratioi
- 1.41
- Amplitudei
- 3.76%
- 52-week rangei
- 161.90 - 428.88
Valuation
- P/Ei
- 40.30
- P/E (TTM)i
- 37.48
- P/Bi
- 2.48
- EPSi
- 9.84
- Book value / shi
- 160.00
- Net profit
- 1.18B
- Net assets
- 19.21B
Share structure
- Market cap
- 47.61B
- Float capi
- 47.51B
- Shares out
- 120.08M
- Float sharesi
- 119.83M
Dividend & listing
- Div yield (TTM)i
- 0.89%
- Dividend (TTM)
- 3.54
- Listing date
- 1970-01-01
7.5% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-16.39M net over the window
Short interest
- Shares short
- 2.85M
- % of floati
- 2.37%
- Days to coveri
- 3.29
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Humana (HUM)?
Humana last traded at 396.51. The quote on this page refreshes every few seconds while US markets are open.
What is Humana's market cap?
About 47.61B.
What is the P/E ratio of Humana?
The trailing twelve-month P/E is 37.48, above its own 5-year average of 22.22 — toward the top of its historical range (94.73% percentile). See the Valuation tab for the full history.
Does Humana pay a dividend?
Yes. The trailing dividend yield is 0.89%. The 2025 payout was little changed from 2024. See the Dividends tab for the full payment history.
Is Humana a buy according to analysts?
The consensus of 22 analysts is a Buy rating, with an average 12-month price target of 428.05, which implies 8.0% upside from the current price. This is not investment advice.
What is Humana's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Humana a B (Buy). Twelve-month momentum in the top 25% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-08 06:48:38 · For reference only, not investment advice and not tailored to your situation.